Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial

Objectives To compare the effectiveness of pharmacist medication review, with or without pharmacist prescribing, with standard care, for patients with chronic pain. Design An exploratory randomised controlled trial. Setting Six general practices with prescribing pharmacists in Grampian (3) and East Anglia (3). Participants Patients on repeat prescribed pain medication (4815) were screened by general practitioners (GPs), and mailed invitations (1397). 196 were randomised and 180 (92%) completed. Exclusion criteria included: severe mental illness, terminally ill, cancer related pain, history of addiction. Randomisation and intervention Patients were randomised using a remote telephone service to: (1) pharmacist medication review with face-to-face pharmacist prescribing; (2) pharmacist medication review with feedback to GP and no planned patient contact or (3) treatment as usual (TAU). Blinding was not possible. Outcome measures Outcomes were the SF-12v2, the Chronic Pain Grade (CPG), the Health Utilities Index 3 and the Hospital Anxiety and Depression Scale (HADS). Outcomes were collected at 0, 3 and 6 months. Results In the prescribing arm (n=70) two patients were excluded/nine withdrew. In the review arm (n=63) one was excluded/three withdrew. In the TAU arm (n=63) four withdrew. Compared with baseline, patients had an improved CPG in the prescribing arm, 47.7% (21/44; p=0.003) and in the review arm, 38.6% (17/44; p=0.001), but not the TAU group, 31.3% (15/48; ns). The SF-12 Physical Component Score showed no effect in the prescribing or review arms but improvement in TAU (p=0.02). The SF-12 Mental Component Score showed no effect for the prescribing or review arms and deterioration in the TAU arm (p=0.002). HADS scores improved within the prescribing arm for depression (p=0.022) and anxiety (p=0.007), between groups (p=0.022 and p=0.045, respectively). Conclusions This is the first randomised controlled trial of pharmacist prescribing in the UK, and suggests that there may be a benefit for patients with chronic pain. A larger trial is required. Trial registration: www.isrctn.org/ISRCTN06131530. Medical Research Council funding.

[1]  Christopher Eccleston,et al.  Psychological therapies for the management of chronic pain (excluding headache) in adults. , 2012, The Cochrane database of systematic reviews.

[2]  Ian C. Reid,et al.  Measuring depression severity in general practice: discriminatory performance of the PHQ-9, HADS-D, and BDI-II. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  Blair H. Smith,et al.  Developing an RCT of general practice-based, pharmacist-led, management of chronic pain: The PIPPC study , 2010 .

[4]  R. Morriss,et al.  Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain – Results from the EPIFUND study , 2009, PAIN®.

[5]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[6]  J. Farrar,et al.  Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain , 2008, PAIN®.

[7]  C. Anderson,et al.  The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. , 2007, Family practice.

[8]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[9]  Blair H. Smith,et al.  The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist. , 2006, Family practice.

[10]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[11]  P. Williamson,et al.  Design and analysis of pilot studies: recommendations for good practice. , 2004, Journal of evaluation in clinical practice.

[12]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[13]  J. Farrar,et al.  Core outcome domains for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[14]  R. Buchbinder,et al.  Physiotherapy interventions for shoulder pain. , 2003, The Cochrane database of systematic reviews.

[15]  Smith Bh,et al.  Chronic pain and the use of conventional and alternative therapy. , 2003, Family practice.

[16]  P. Hannaford,et al.  The course of chronic pain in the community: results of a 4-year follow-up study , 2002, PAIN.

[17]  高松 潔,et al.  婦人科入院患者におけるメンタルヘルス : HADS(Hospital Anxiety and Depression Scale)を用いた検討 , 2001 .

[18]  L. Carmona,et al.  The burden of musculoskeletal diseases in the general population of Spain: results from a national survey , 2001, Annals of the rheumatic diseases.

[19]  J. Krska,et al.  Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. , 2001, Age and ageing.

[20]  Blair H. Smith,et al.  The epidemiology of chronic pain in the community , 1999, The Lancet.

[21]  O. Gureje,et al.  Persistent Pain and Well Being: a World Health Organization Study in Primary Care , 1999 .

[22]  O. Gureje,et al.  Persistent pain and well-being: a World Health Organization Study in Primary Care. , 1998, JAMA.

[23]  P. Bech,et al.  Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center , 1997, Pain.

[24]  D. Osoba,et al.  Letters to the editor: Assessing quality of life in clinical trials , 1993 .

[25]  H. Merskey,et al.  Chronic musculoskeletal pain and depressive symptoms in the national health and nutrition examination I. Epidemiologic follow-up study , 1993, Pain.

[26]  S. Dworkin,et al.  Grading the severity of chronic pain , 1992, Pain.

[27]  J. Turner,et al.  Chronic pain in primary care. Identification and management of psychosocial factors. , 1991, The Journal of family practice.

[28]  H. Merskey,et al.  Chronic musculoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data , 1990, Pain.

[29]  Huston Gj,et al.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[30]  R. Snaith,et al.  Doctors and overpopulation , 1986 .

[31]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[32]  A. Zigmond,et al.  The Hospital Anxiety and Depression Scale , 1983, Acta psychiatrica Scandinavica.

[33]  Frank Sullivan,et al.  Strategies to improve recruitment to randomised controlled trials. , 2010, The Cochrane database of systematic reviews.

[34]  S. Closs,et al.  A feasibility study of a combined nurse/pharmacist-led chronic pain clinic in primary care. , 2008, Quality in primary care.

[35]  J. Ware,et al.  User’s manual for the SF-12v2 Health Survey (with a supplement Documenting SF-12 Health Survey) , 2007 .

[36]  J. Ware,et al.  User’s manual for the SF-12v2 health survey , 2002 .

[37]  高松潔.  女性メンタルヘルスケアへのHADS (Hospital Anxiety and Depression Scale) の応用 , 2002 .

[38]  Blair H. Smith,et al.  Researching chronic pain: Identification of a community based sample , 1996 .

[39]  D. Osoba,et al.  Assessing quality of life in clinical trials. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  R. Rosenthal.  Meta-analytic procedures for social research , 1984 .